| IPI00364785 - E2f1, SIMILAR TO TRANSCRIPTION FACTOR E2F1. | |
|---|---|
| Uniprot Accession: -NA- | |
| Uniprot ID: -NA- | |
| Mapping: Chr 3, 145032716 - 145054799 | |
| Entrez Gene: 399489 | |
| Entrez MapView: |
|
| RGD: 728892 | |
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_3918) |
|---|
| Rat: E2f1, SIMILAR TO TRANSCRIPTION FACTOR E2F1. |
| Mouse: E2f1, TRANSCRIPTION FACTOR E2F1. |
| Mouse: E2f1, SEQUENCE. |
| Rat: E2f1, SIMILAR TO TRANSCRIPTION FACTOR E2F1. |
| Human: E2F1, TRANSCRIPTION FACTOR E2F1. |
| Human: E2F1, UNCHARACTERIZED PROTEIN E2F1. |
| Human: E2F1, SIMILAR TO E2F TRANSCRIPTION FACTOR 1 (FRAGMENT). |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cytoplasm | C | IEA | IDA | ISS IEA |
| transcription factor complex | C | IEA | IDA | ISS IEA |
| nucleus | C | IEA | IDA IDA | ISS IEA |
| transcription corepressor activity | F | TAS | ISS | |
| transcription activator activity | F | IEA | IDA IDA | ISS IEA |
| transcription factor activity | F | TAS IDA IEA | IDA IDA IDA IDA | TAS ISS ISS IEA |
| protein binding | F | IPI IPI | IPI IPI | ISS ISS IPI |
| DNA binding | F | ISS | ||
| transcription factor binding | F | IPI | ||
| regulation of progression through cell cycle | P | IEA | IDA | ISS IEA |
| G1/S transition of mitotic cell cycle | P | TAS | ||
| forebrain development | P | IEA | IMP | ISS IEA |
| G1 phase of mitotic cell cycle | P | TAS | ISS | |
| regulation of transcription | P | IDA IDA | ISS | |
| cell proliferation | P | TAS | ISS | |
| apoptosis | P | TAS | IDA IDA | ISS ISS IEA |
| positive regulation of transcription from RNA polymerase II promoter | P | IEA | IDA | ISS IEA |
| cell cycle | P | IEA | IEA | |
| transcription | P | IEA | IEA | IEA |
| regulation of transcription, DNA-dependent | P | IEA | IDA | ISS IEA |
| positive regulation of transcription, DNA-dependent | P | IDA IDA IDA | ISS | |
| negative regulation of transcription from RNA polymerase II promoter | P | TAS | ISS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cellular phenotype | MP | Un | ||
| life span-post-weaning/aging | MP | Un | ||
| endocrine/exocrine gland phenotype | MP | Un | ||
| growth/size phenotype | MP | Un | ||
| immune system phenotype | MP | Un | ||
| hearing/vestibular/ear phenotype | MP | Un | ||
| reproductive system phenotype | MP | Un | ||
| hematopoietic system phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| tumorigenesis | MP | Un | ||
| abnormal thymus development | N | ISS | ||
| exocrine pancreas hypoplasia | N | ISS | ||
| abnormal apoptosis | N | ISSISS | ||
| decreased circulating insulin level | N | ISS | ||
| cellular dysplasia | N | ISS | ||
| increased T cell proliferation | N | ISS | ||
| abnormal pancreas secretion | N | ISS | ||
| abnormal islet of Langerhans morphology | N | ISS | ||
| increased insulin sensitivity | N | ISS | ||
| increased tumor incidence | N | ISS | ||
| small testis | N | ISS |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glioma (05214) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Chronic myeloid leukemia (05220) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Cell cycle (04110) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Pancreatic cancer (05212) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |